AllianceBernstein’s CorMedix CRMD Stock Holding History

AllianceBernstein’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$419K	Hold	61,780	–	–	﹤0.01%	2824
2026 Q1	$719K	Hold	61,780	–	–	﹤0.01%	2473
2025 Q4	$719K	Hold	61,780	–	–	﹤0.01%	2481
2025 Q3	$719K	Hold	61,780	–	–	﹤0.01%	2500
2025 Q2	$761K	Buy	61,780 +12,000	+24%	+$132K	﹤0.01%	2434
2025 Q1	$307K	Hold	49,780	–	–	﹤0.01%	2765
2024 Q4	$403K	Buy	49,780 +17,250	+53%	+$172K	﹤0.01%	2731
2024 Q3	$263K	Buy	32,530 +9,910	+44%	+$53.6K	﹤0.01%	2970
2024 Q2	$97.9K	Buy	22,620 +9,120	+68%	+$46.3K	﹤0.01%	3124
2024 Q1	$57.2K	Hold	13,500	–	–	﹤0.01%	3077
2023 Q4	$50.8K	Hold	13,500	–	–	﹤0.01%	3128
2023 Q3	$50K	Buy	+13,500	New	+$53.7K	﹤0.01%	3138
2022 Q2	–	Sell	-23,300	Closed	-$128K	–	3284
2022 Q1	$128K	Hold	23,300	–	–	﹤0.01%	3088
2021 Q4	$106K	Hold	23,300	–	–	﹤0.01%	3188
2021 Q3	$108K	Hold	23,300	–	–	﹤0.01%	3179
2021 Q2	$160K	Buy	23,300 +3,000	+15%	+$23.9K	﹤0.01%	3201
2021 Q1	$203K	Hold	20,300	–	–	﹤0.01%	3061
2020 Q4	$151K	Hold	20,300	–	–	﹤0.01%	3051
2020 Q3	$122K	Hold	20,300	–	–	﹤0.01%	3047
2020 Q2	$128K	Buy	20,300 +9,100	+81%	+$42.1K	﹤0.01%	3075
2020 Q1	$40K	Buy	+11,200	New	+$63.3K	﹤0.01%	3074
2019 Q1	–	Sell	-2,000	Closed	-$13K	–	3118
2018 Q4	$13K	Buy	+2,000	New	+$13.4K	﹤0.01%	3091
2016 Q2	–	Sell	-2,020	Closed	-$27K	–	2968
2016 Q1	$27K	Hold	2,020	–	–	﹤0.01%	2895
2015 Q4	$21K	Hold	2,020	–	–	﹤0.01%	2910
2015 Q3	$20K	Hold	2,020	–	–	﹤0.01%	2934
2015 Q2	$39K	Buy	+2,020	New	+$69.3K	﹤0.01%	2982

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AllianceBernstein's CRMD Position: Q2 2026 in Review

AllianceBernstein held its CorMedix (CRMD) position steady in Q2 2026 at 61,780 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #2824.

AllianceBernstein first reported a position in CRMD in Q2 2015 and has held it in 26 quarters since. The position peaked at $761K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

AllianceBernstein held 61,780 shares of CorMedix worth $419K as of Q2 2026.
AllianceBernstein left its CorMedix share count unchanged in Q2 2026.
CorMedix made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2824 holding.
AllianceBernstein first reported a position in CorMedix in Q2 2015 and has held it in 26 quarters since.
AllianceBernstein's CorMedix position peaked at $761K in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.